Buononato, D. et al. 2022. Tildrakizumab: Successful Response in Two Patients with Psoriatic Arthritis. Dermatology Practical & Conceptual. 12, 2 (May 2022), e2022049. DOI:https://doi.org/10.5826/dpc.1202a49.